A supplier suspends shipping to the United Arab Emirates after 6 consecutive customs detentions
The route did not close because of a rule about peptides.
TheCompound Journal
Reporting on incretins, compounding & the peptide supply chain
Page 7 of 13 of this archive, newest first.
The route did not close because of a rule about peptides.
The route did not close because of a rule about peptides.
The route did not close because of a rule about peptides.
The route did not close because of a rule about peptides.
The route did not close because of a rule about peptides.
Efficacy was never the question in this appraisal. Duration of treatment was.
The route did not close because of a rule about peptides.
What a laboratory can and cannot know about the provenance, storage history and representativeness of what lands on its bench.
Every third-party report in this market describes a sample somebody chose to send. That choice is outside the laboratory’s control and outside its records.
The route did not close because of a rule about peptides.
Lot-level verification with a public report is a real and achievable thing. It exists in this market, on a minority of listings.
Efficacy was never the question in this appraisal. Duration of treatment was.
A badge asserts that something was tested. It does not assert what, when, on whose sample, by what method, or whether the lot on sale is the lot that was tested.
An isoaspartate rearrangement changes the molecule and not the mass. A method that confirms identity by molecular weight alone will report it as the parent compound.
The route did not close because of a rule about peptides.
Every degradation pathway accelerates by orders of magnitude on reconstitution, because the solvent that lyophilisation removed is the reagent most of them need.
The route did not close because of a rule about peptides.
The route did not close because of a rule about peptides.
The route did not close because of a rule about peptides.
The route did not close because of a rule about peptides.